Compounds > platinum
Page last updated: 2024-08-22

platinum and Microsatellite Instability

platinum has been researched along with Microsatellite Instability in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Bartoletti, M; Canzonieri, V; Clemente, N; Corsetti, S; Fornasarig, M; Giorda, G; Lucia, E; Nicoloso, MS; Palazzari, E; Pivetta, T; Puglisi, F; Scalone, S; Segatto, E; Sorio, R; Viel, A; Zdjelar, A1
Alexandre, J; Brachet, PE; Colomba, E; Coquard, IR; Coupez, D; de Percin, S; Delanoy, N; Fabbro, M; Frenel, JS; Genestie, C; Joly, F; Le Teuff, G; Leary, A; Pautier, P; Sajous, C1
Angeli, E; Boudier, P; de la Motte Rouge, T; Delanoy, N; Eberst, L; El Mouaddin, N; Fiteni, F; Flippot, R; Follana, P; Gauthier, L; Jacquemin, V; Roche, S; Rodrigues, M; Sabatier, R; Tessier, C1

Other Studies

3 other study(ies) available for platinum and Microsatellite Instability

ArticleYear
An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer.
    Current oncology (Toronto, Ont.), 2022, 07-22, Volume: 29, Issue:8

    Topics: Antibodies, Monoclonal, Humanized; Brain Neoplasms; Colorectal Neoplasms; DNA Mismatch Repair; Endometrial Neoplasms; Female; Humans; Immune Checkpoint Inhibitors; Microsatellite Instability; Neoplastic Syndromes, Hereditary; Platinum; Programmed Cell Death 1 Receptor

2022
Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/ microsatellite instability high (MSI-high) endometrial carcinoma.
    Gynecologic oncology, 2023, Volume: 169

    Topics: Colorectal Neoplasms; DNA Mismatch Repair; Endometrial Neoplasms; Female; Humans; Microsatellite Instability; Platinum; Retrospective Studies

2023
Real-world dostarlimab use in advanced/recurrent endometrial cancer in France.
    Bulletin du cancer, 2023, Volume: 110, Issue:10

    Topics: Antibodies, Monoclonal, Humanized; Chronic Disease; Clinical Trials as Topic; DNA Mismatch Repair; Endometrial Neoplasms; Female; Humans; Microsatellite Instability; Platinum; Prospective Studies

2023